Supernus Pharmaceuticals, Inc. (SUPN)
53.76
-0.51
(-0.94%)
USD |
NASDAQ |
Mar 06, 15:12
Supernus Pharmaceuticals Cash from Investing (Quarterly) : -51.31M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -1.232B |
| BridgeBio Pharma, Inc. | -13.75M |
| Corcept Therapeutics, Inc. | -11.84M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Cytokinetics, Inc. | -71.19M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 19.86M |
| Cash from Financing (Quarterly) | 8.526M |
| Free Cash Flow | 45.99M |
| Free Cash Flow Per Share (Quarterly) | 0.3389 |
| Free Cash Flow to Equity (Quarterly) | 20.67M |
| Free Cash Flow to Firm (Quarterly) | 19.43M |
| Free Cash Flow Yield | 1.51% |